Arcus Biosciences announced that the Food and Drug Administration has granted its pancreatic cancer treatment, quemliclustat, with an orphan drug designation. The company said it expects its ongoing ...

The test claims to analyse epigenomic and genomic data from circulating, cell-free DNA obtained from a simple blood draw.